Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Gastroenterology and Hepatology|March 23, 2013
Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patientsHan Wu, Pei Chen, Rui Liao, et al.
Acta Pharmacologica Sinica|December 22, 2018
A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamstersMao-Xu Ge, Wei-Xiao Niu, Jin-Feng Ren, et al.
International Immunopharmacology|December 29, 2025
IMB16-5 alleviates liver fibrosis by targeting MICALL2/β-catenin signalingMao-Xu Ge, Dong Liu, Ting-Chao Liu, et al.
World Journal of Surgery|August 15, 2012
Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patientsLong-Rong Wang, Jia-Min Zhou, Yi-Ming Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancerYue-Ming Wang, Lai-Xing Hu, Zhen-Ming Liu, et al.
Journal of Cancer Research and Clinical Oncology|June 16, 2010
Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resectionDan-Dan Wang, Yi-Ming Zhao, Lu Wang, et al.
Pageof 9